Injeq Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 16
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 4

Injeq General Information

Description

Manufacturer of a bio-impedance measurement device designed to help in promoting efficiency in surgeries. The company's device is made in the form of a needle that knows the physiological condition of organs and also performs tissue identification, enabling surgeons to perform high precision surgeries with perfection and efficiency.

Contact Information

Website
www.injeq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Diagnostic Equipment
Primary Office
  • Biokatu 8
  • 33520 Tampere
  • Finland
+358 040 0000000

Injeq Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Injeq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 01-Jan-2021 00.000 Completed Generating Revenue
8. Equity Crowdfunding 18-Nov-2020 00.000 00.000 0000 Completed Generating Revenue
7. Equity Crowdfunding 31-Jul-2019 00.00 00.00 000.00 Completed Generating Revenue
6. Equity Crowdfunding 04-Jul-2017 00.000 000 00.000 Completed Generating Revenue
5. Debt - General 01-Jan-2017 00000 00.000 Completed Generating Revenue
4. Grant 01-Jan-2017 00000 00000 Completed Generating Revenue
3. Early Stage VC 21-Dec-2016 00000 Completed Generating Revenue
2. Seed Round 29-Dec-2015 $272K $272K 00.000 Completed Startup
1. Seed Round 01-Jan-2013 Completed Startup
To view Injeq’s complete valuation and funding history, request access »

Injeq Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.00 00.00 00 00.00 00.000
Ordinary 129,792 $2.28 $2.28 1x $2.28 2.87%
To view Injeq’s complete cap table history, request access »

Injeq Patents

Injeq Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3484373-A1 A biopsy gun, a biopsy needle, a biopsy sample collecting system and a method for connecting at least one needle electrode of a biopsy needle to a connector and/or to a measurement cable in a biopsy gun Granted 16-Jul-2016 00000000000
EP-3484373-B1 A biopsy gun, a biopsy sample collecting system and a method for connecting at least one needle electrode of a biopsy needle to a connector and/or to a measurement cable in a biopsy gun Active 16-Jul-2016 00000000000
US-10779804-B2 Biopsy needle for biopsy sampling, biopsy device, and methods of manufacturing a biopsy needle or a biopsy device Active 07-Jun-2015 00000000000
US-20180296197-A1 Biopsy needle for biopsy sampling, biopsy device, and methods of manufacturing a biopsy needle or a biopsy device Granted 07-Jun-2015 00000000000
EP-3302290-B1 Biopsy needle for biopsy sampling, biopsy device, and methods of manufacturing a biopsy needle or a biopsy device Active 07-Jun-2015 A61B10/0275
To view Injeq’s complete patent history, request access »

Injeq Executive Team (12)

Name Title Board Seat Contact Info
Ilari Antila Chief Executive Officer
Satu Sinisalo Chief Financial Officer
Timo Elomaa Chief Operating Officer
Harri Sievänen Chief Scientific Officer
Petri Ahonen Chief Manufacturing Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Injeq Board Members (10)

Name Representing Role Since
Jan Lindgren Ph.D Injeq Board Member 000 0000
Jari Hyttinen Ph.D Injeq Board Member 000 0000
Katja Paassilta MD Injeq Co-Founder & Board Member 000 0000
Riitta Seppänen-Kaijansinkko Ph.D Injeq Co-Founder & Board Member 000 0000
Timur Karki Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Injeq Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Injeq Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tesi Fund of Funds Minority 000 0000 000000 0
Ely Keskus Corporation Minority 000 0000 000000 0
Finnish Business Angels Network Not-For-Profit Venture Capital Minority 000 0000 000000 0
Finnvera Venture Capital Minority 000 0000 000000 0
To view Injeq’s complete investors history, request access »